275 related articles for article (PubMed ID: 36674847)
1. Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome.
Arachchillage DJ; Laffan M; Pericleous C
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674847
[TBL] [Abstract][Full Text] [Related]
2. Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome.
Bertolaccini ML; Contento G; Lennen R; Sanna G; Blower PJ; Ma MT; Sunassee K; Girardi G
J Autoimmun; 2016 Dec; 75():30-38. PubMed ID: 27160365
[TBL] [Abstract][Full Text] [Related]
3. Evolution of Antiphospholipid Syndrome.
Arachchillage DRJ; Pericleous C
Semin Thromb Hemost; 2023 Apr; 49(3):295-304. PubMed ID: 36646109
[TBL] [Abstract][Full Text] [Related]
4. Current status and future prospects for the treatment of antiphospholipid syndrome.
Al Marzooqi A; Leone A; Al Saleh J; Khamashta M
Expert Rev Clin Immunol; 2016 Sep; 12(9):927-35. PubMed ID: 27117597
[TBL] [Abstract][Full Text] [Related]
5. The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study.
Kravvariti E; Koutsogianni A; Samoli E; Sfikakis PP; Tektonidou MG
Autoimmun Rev; 2020 Apr; 19(4):102491. PubMed ID: 32084592
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome.
Belizna C
Autoimmun Rev; 2015 Apr; 14(4):358-62. PubMed ID: 25534016
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid syndrome - an update.
Linnemann B
Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
[TBL] [Abstract][Full Text] [Related]
8. Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome.
Liu J; Zhang L; Tian Y; Wan S; Hu M; Song S; Zhang M; Zhou Q; Xia Y; Wang X
J Cell Mol Med; 2022 Aug; 26(15):4357-4370. PubMed ID: 35770338
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases.
Khizroeva J; Bitsadze V; Tincani A; Makatsariya A; Arslanbekova M; Babaeva N; Tsibizova V; Shkoda A; Makatsariya N; Tretyakova M; Solopova A; Gadaeva Z; Vorobev A; Khamani I; Aslanova Z; Nakaidze I; Mischenko A; Grigoreva K; Kunesko N; Egorova E; Mashkova T
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6157-6164. PubMed ID: 34044735
[TBL] [Abstract][Full Text] [Related]
10. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].
Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O
Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771
[TBL] [Abstract][Full Text] [Related]
11. [Management of the antiphospholipid syndrome in adults].
Doms J; Horisberger A; Ribi C
Rev Med Suisse; 2020 Apr; 16(689):670-674. PubMed ID: 32270932
[TBL] [Abstract][Full Text] [Related]
12. Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease.
Erkan D; Unlu O; Sciascia S; Belmont HM; Branch DW; Cuadrado MJ; Gonzalez E; Knight JS; Uthman I; Willis R; Zhang Z; Wahl D; Zuily S; Tektonidou MG;
Lupus; 2018 Mar; 27(3):399-406. PubMed ID: 28764618
[TBL] [Abstract][Full Text] [Related]
13. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.
Erkan D; Aguiar CL; Andrade D; Cohen H; Cuadrado MJ; Danowski A; Levy RA; Ortel TL; Rahman A; Salmon JE; Tektonidou MG; Willis R; Lockshin MD
Autoimmun Rev; 2014 Jun; 13(6):685-96. PubMed ID: 24468415
[TBL] [Abstract][Full Text] [Related]
14. Effect of hydroxychloroquine on antiphospholipid antibodies-inhibited endometrial angiogenesis.
Dong Y; Lu Y; Xia Y; Wang X
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7084-7092. PubMed ID: 34182874
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies.
Islam MA; Alam F; Wong KK; Kamal MA; Gan SH
Curr Vasc Pharmacol; 2017; 15(4):313-326. PubMed ID: 28056758
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of the antiphospholipid syndrome.
Chaturvedi S; McCrae KR
Blood Rev; 2017 Nov; 31(6):406-417. PubMed ID: 28784423
[TBL] [Abstract][Full Text] [Related]
17. Current management of antiphospholipid syndrome-related thrombosis.
Puente D; Pombo G; Forastiero R
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
[TBL] [Abstract][Full Text] [Related]
18. Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment.
Chighizola CB; Meroni PL
Curr Rheumatol Rep; 2018 May; 20(7):44. PubMed ID: 29850957
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid syndrome.
Lim W
Hematology Am Soc Hematol Educ Program; 2013; 2013():675-80. PubMed ID: 24319251
[TBL] [Abstract][Full Text] [Related]
20. Emerging Therapies in Antiphospholipid Syndrome.
Hubben A; McCrae KR
Transfus Med Rev; 2022 Oct; 36(4):195-203. PubMed ID: 36272841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
